DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 139 filers reported holding DIPLOMAT PHARMACY INC in Q3 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $78,000 | -18.8% | 19,575 | +0.1% | 0.00% | -50.0% |
| Q3 2019 | $96,000 | -18.6% | 19,547 | +0.5% | 0.00% | 0.0% |
| Q2 2019 | $118,000 | +4.4% | 19,447 | +0.1% | 0.00% | 0.0% |
| Q1 2019 | $113,000 | -56.7% | 19,426 | +0.1% | 0.00% | -60.0% |
| Q4 2018 | $261,000 | -0.4% | 19,408 | +43.8% | 0.01% | +25.0% |
| Q3 2018 | $262,000 | +0.4% | 13,500 | +32.4% | 0.00% | 0.0% |
| Q2 2018 | $261,000 | – | 10,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |